TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionHighTower Advisors, LLC
Latest Disclosed Ownership25,273 shares
Latest Disclosed Value $ 839,569
HighTower Advisors, LLC ownership in 1TGTX / TG Therapeutics, Inc.

On May 5, 2026 - HighTower Advisors, LLC filed a 13F-HR form disclosing ownership of 25,273 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $699,051 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 23,282 shares of TG Therapeutics, Inc.. This represents a change in shares of 8.55% during the quarter. The current value of the position is $859,282 USD.

HighTower Advisors, LLC has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 25,273 1,991 8.55 840 20.89 0.0009
2026-02-06 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 23,282 -4,511 -16.23 694 -30.88 0.0008
2025-11-07 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 27,793 4,143 17.52 1,004 17.98 0.0011
2025-08-11 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 23,650 759 3.32 851 -5.65 0.0011
2025-05-13 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 22,891 7,979 53.51 903 101.34 0.0012
2025-02-07 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 14,912 2,386 19.05 449 52.38 0.0006
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 12,526 2,053 19.60 294 58.06 0.0004
2024-08-13 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 10,473 -67 -0.64 186 16.25 0.0003
2024-05-06 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 10,540 65 0.62 160 -11.11 0.0003
2024-02-12 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 10,475 -188 -1.76 180 100.00 0.0003
2023-11-08 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 10,663 -523 -4.68 90 -67.51 0.0002
2023-08-14 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 11,186 -2,539 -18.50 277 33.82 0.0005
2023-05-12 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 13,725 -1,577 -10.31 207 14.36 0.0005
2023-02-09 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 15,302 -1,226 -7.42 181 84.69 0.0004
2022-11-09 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 16,528 -75 -0.45 98 42.03 0.0003
2022-08-10 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 16,603 3,000 22.05 69 -46.51 0.0002
2022-05-12 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 13,603 2,998 28.27 129 -36.14 0.0003
2022-02-10 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 10,605 -10,479 -49.70 202 -71.18 0.0004
2021-11-12 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 21,084 -85 -0.40 701 -14.72 0.0019
2021-08-06 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 21,169 5,225 32.77 822 7.03 0.0024
2021-05-10 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 15,944 1,041 6.99 768 -1.54 0.0024
2021-02-10 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 14,903 -1,272 -7.86 780 80.14 0.0032
2020-11-13 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 16,175 -1,524 -8.61 433 25.51 0.0021
2020-08-10 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 17,699 -500 -2.75 345 92.74 0.0019
2020-05-21 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 18,199 -38,283 -67.78 179 -71.63 0.0012
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 56,482 39,382 230.30 631 557.29 0.0037
2019-11-12 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 17,100 2,500 17.12 96 -24.41 0.0005
2019-08-13 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 14,600 -2,000 -12.05 127 -4.51 0.0008
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 16,600 500 3.11 133 101.52 0.0009
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 16,100 750 4.89 66 -22.35 0.0005
2018-11-09 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 15,350 950 6.60 85 -55.03 0.0006
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 14,400 0 0.00 189 -7.35 0.0015
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 14,400 3,000 26.32 204 119.35 0.0017
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 11,400 300 2.70 93 -29.55 0.0008
2017-11-14 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 11,100 -300 -2.63 132 15.79 0.0011
2017-09-22 2017-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 11,400 -3,906 -25.52 114 -32.94 0.0010
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 11,400 -3,906 114
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 15,306 15,306 170 0.0016
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-08-13 2019-06-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM Call 1,500 50.00 3 200.00 n/a n/a n/a
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM Call 1,000 0.00 1 0.00 n/a n/a n/a
2018-11-09 2018-09-30 13F TG THERAPEUTICS COM Call 1,000 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.